Boehringer Ingelheim GmbH seeks a Director of Early Safety Immunology to lead immune safety efforts across discovery, preclinical, and clinical development. The role entails strategic oversight, resource allocation, and collaboration with IU, CPS TAs, CI and Discovery Research to mitigate immune-related safety risks.
The candidate will guide scientists, develop novel models/technologies, and ensure high-quality data interpretation to support portfolio decisions, while mentoring staff and
#J-18808-LjbffrDirector, Early Safety Immunology — Hybrid/Remote in ridgefield at Unknown Company
This position is listed as full time and onsite.